US FDA wishes for development scheme for Aurobindo’s unit

Drug manufacturer Aurobindo Pharma has told that on Monday it has obtained an advisory letter from the US FDA based on a field alert account for packaging and labeling conformity for unit-ill, looking for a detailed scheme for development.